Rinaldi, R.; Miglionico, R.; Nigro, I.; D’Orsi, R.; Chiummiento, L.; Funicello, M.; Lupattelli, P.; Laurenzana, I.; Sgambato, A.; Monné, M.;
et al. Two Novel Precursors of the HIV-1 Protease Inhibitor Darunavir Target the UPR/Proteasome System in Human Hepatocellular Carcinoma Cell Line HepG2. Cells 2021, 10, 3052.
https://doi.org/10.3390/cells10113052
AMA Style
Rinaldi R, Miglionico R, Nigro I, D’Orsi R, Chiummiento L, Funicello M, Lupattelli P, Laurenzana I, Sgambato A, Monné M,
et al. Two Novel Precursors of the HIV-1 Protease Inhibitor Darunavir Target the UPR/Proteasome System in Human Hepatocellular Carcinoma Cell Line HepG2. Cells. 2021; 10(11):3052.
https://doi.org/10.3390/cells10113052
Chicago/Turabian Style
Rinaldi, Roberta, Rocchina Miglionico, Ilaria Nigro, Rosarita D’Orsi, Lucia Chiummiento, Maria Funicello, Paolo Lupattelli, Ilaria Laurenzana, Alessandro Sgambato, Magnus Monné,
and et al. 2021. "Two Novel Precursors of the HIV-1 Protease Inhibitor Darunavir Target the UPR/Proteasome System in Human Hepatocellular Carcinoma Cell Line HepG2" Cells 10, no. 11: 3052.
https://doi.org/10.3390/cells10113052
APA Style
Rinaldi, R., Miglionico, R., Nigro, I., D’Orsi, R., Chiummiento, L., Funicello, M., Lupattelli, P., Laurenzana, I., Sgambato, A., Monné, M., Bisaccia, F., & Armentano, M. F.
(2021). Two Novel Precursors of the HIV-1 Protease Inhibitor Darunavir Target the UPR/Proteasome System in Human Hepatocellular Carcinoma Cell Line HepG2. Cells, 10(11), 3052.
https://doi.org/10.3390/cells10113052